<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The aim of this study was to evaluate the early and long-term outcomes in patients undergoing a Bentall procedure or its button modification for <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo> with <z:e sem="disease" ids="C0003504" disease_type="Disease or Syndrome" abbrv="ai">aortic valve incompetence</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Between January 1986 and January 2002, 65 patients (84% males, mean age 58.9 +/- 11 years) underwent aortic root replacement with a Bentall or a button-Bentall operation </plain></SENT>
<SENT sid="2" pm="."><plain>Annuloaortic <z:mpath ids='MPATH_474'>ectasia</z:mpath> was the most frequent cause of <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> in this series (n = 37, 56.9%), followed by atherosclerotic <z:hpo ids='HP_0002617'>aneurysms</z:hpo> (n = 22, 33.9%), and post-stenotic dilation (n = 5, 7.7%) </plain></SENT>
<SENT sid="3" pm="."><plain>One patient (1.5%) underwent redo aortic root replacement,3 (4.6%) had a <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, and 6 (9.2%) underwent a concomitant replacement of the aortic arch </plain></SENT>
<SENT sid="4" pm="."><plain>The duration of follow-up ranged from 2 to 192 months (mean 89.6 +/- 21.8 months) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The 30-day mortality was 0% </plain></SENT>
<SENT sid="6" pm="."><plain>Early non-fatal complications comprised: <z:mp ids='MP_0001914'>bleeding</z:mp> requiring surgical re-exploration (n = 1, 1.5%), low output syndrome (n = 1, 1.5%), <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo> (n = 1, 1.5%), <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (n = 2, 3.1%), <z:hpo ids='HP_0001297'>stroke</z:hpo> (n = 1, 1.5%), and <z:hpo ids='HP_0010444'>pulmonary insufficiency</z:hpo> (n = 1, 1.5%) </plain></SENT>
<SENT sid="7" pm="."><plain>There was a late <z:hpo ids='HP_0011420'>death</z:hpo> due to a pulmonary <z:hpo ids='HP_0002664'>neoplasm</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The 16-year actuarial survival was 97 +/- 2% (hazard 0.02 +/- 0.02) </plain></SENT>
<SENT sid="9" pm="."><plain>No patient required reoperation </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, the long-term clinical follow-up was characterized by the complete absence of <z:hpo ids='HP_0100584'>endocarditis</z:hpo>, <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>-related <z:mp ids='MP_0001914'>hemorrhage</z:mp>, valve <z:mp ids='MP_0005048'>thrombosis</z:mp>, and prosthetic failure </plain></SENT>
<SENT sid="11" pm="."><plain>Finally, the NYHA functional status was significantly improved (1.1 +/- 0.50, p &lt; 0.001 vs preoperatively) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: The late results of the Bentall and button-Bentall procedures were excellent </plain></SENT>
<SENT sid="13" pm="."><plain>Our findings confirm that these techniques still constitute the gold standard in the surgical treatment of combined valve and ascending aorta pathologies </plain></SENT>
</text></document>